361 Capital’s Protolabs PRLB Stock Holding History

361 Capital’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-21,557	Closed	-$2.43M	–	388
2018 Q4	$2.43M	Buy	+21,557	New	+$2.66M	0.5%	55

Other funds holding PRLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

361 Capital's PRLB Position: Q1 2019 in Review

361 Capital sold out of Protolabs (PRLB) in Q1 2019, closing a stake of 21,557 shares — an estimated $2.43M sold.

361 Capital first reported a position in PRLB in Q4 2018 and held it in 1 quarter. The position peaked at $2.43M in Q4 2018. 266 funds tracked by Wall St. Rank hold PRLB as of Q1 2019.

361 Capital reported no remaining Protolabs position as of Q1 2019 after selling out during the quarter.
361 Capital sold 21,557 Protolabs shares in Q1 2019, an estimated $2.43M.
361 Capital first reported a position in Protolabs in Q4 2018 and held it in 1 quarter.
361 Capital's Protolabs position peaked at $2.43M in Q4 2018.
266 funds tracked by Wall St. Rank held Protolabs as of Q1 2019.

Based on 361 Capital's 13F filing for Q1 2019, filed 7 May 2019.